BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7409723)

  • 1. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
    Fortschr Med; 1980 Aug; 98(32):1227-8. PubMed ID: 7409723
    [No Abstract]   [Full Text] [Related]  

  • 2. Three large-scale clinical trials of aspirin in the USA.
    Krol WF
    Proc R Soc Med; 1977; 70 Suppl 7(Suppl 7):24-7. PubMed ID: 353816
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
    Lubsen J
    Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention and treatment of recurrences of myocardial infarction. Results in 2026 patients monitored for 44 months in a group study].
    Sem Hop; 1980 Oct 18-25; 56(39-40):1575-7. PubMed ID: 6255571
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
    van der Meer J; Wouda AA; Kallenberg CG; Wesseling H
    Vasa Suppl; 1987; 18():71-5. PubMed ID: 3299819
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of claudication with dipyridamole and aspirin.
    Libretti A; Catalano M
    Int J Clin Pharmacol Res; 1986; 6(1):59-60. PubMed ID: 3514494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of re-occlusion after recanalisation of occluded arteries by the catheter method (author's transl)].
    Hess H; Müller-Fassbender H; Ingrisch H; Mietaschk A
    Dtsch Med Wochenschr; 1978 Dec; 103(50):1994-7. PubMed ID: 720236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
    Statham B; Finlay AY; Marks R
    Acta Derm Venereol; 1981; 61(3):270-1. PubMed ID: 6167117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 11. Migraine prophylaxis: a new approach.
    Ryan RE; Ryan RE
    Laryngoscope; 1981 Sep; 91(9 Pt 1):1501-6. PubMed ID: 7346693
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments in favor of aggregation inhibitors].
    Walter E; Weber E
    Internist (Berl); 1980 Jul; 21(7):387-9. PubMed ID: 7007276
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats.
    Aldandashi S; Noor R; Wang CX; Uddin G; Shuaib A
    Exp Neurol; 2007 Jun; 205(2):563-8. PubMed ID: 17466978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of reinfarction with acetylsalicylic acid].
    Vogel G; Fischer C; Huyke R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):797-803. PubMed ID: 94871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antithrombotic treatment and prevention of recurrence with acetylsalicylic acid in myocardial infarct].
    Heuchel G; Hässler W
    Z Gesamte Inn Med; 1976 Feb; 31(3):61-5. PubMed ID: 1085534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary prevention of myocardial infarct. Evaluation of a 2-year trial comparing acetylsalicylic acid to oral anticoagulants].
    Rev Prat; 1978 Jan; 28(1):43-56. PubMed ID: 635389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term medicinal prevention in patients who have suffered myocardial infarction].
    Doĭchinov A; Buchvarova B
    Vutr Boles; 1974; 13(5):24-9. PubMed ID: 4467458
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
    Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
    Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.